Foghorn Free Cash Flow Yield from 2010 to 2025

FHTX Stock  USD 4.66  0.14  2.92%   
Foghorn Therapeutics Free Cash Flow Yield yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Yield is likely to outpace its year average in 2025. Free Cash Flow Yield is a financial solvency ratio that compares the free cash flow per share Foghorn Therapeutics is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. View All Fundamentals
 
Free Cash Flow Yield  
First Reported
2010-12-31
Previous Quarter
(0.40)
Current Value
(0.38)
Quarterly Volatility
0.25463624
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Foghorn Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Foghorn Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 12.8 M, Interest Income of 12.8 M or Depreciation And Amortization of 3.9 M, as well as many indicators such as Price To Sales Ratio of 8.66, Dividend Yield of 0.0 or Days Sales Outstanding of 66.4 K. Foghorn financial statements analysis is a perfect complement when working with Foghorn Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Foghorn Therapeutics Correlation against competitors.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn Therapeutics guide.

Latest Foghorn Therapeutics' Free Cash Flow Yield Growth Pattern

Below is the plot of the Free Cash Flow Yield of Foghorn Therapeutics over the last few years. It is a financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. Foghorn Therapeutics' Free Cash Flow Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Foghorn Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Yield10 Years Trend
Pretty Stable
   Free Cash Flow Yield   
       Timeline  

Foghorn Free Cash Flow Yield Regression Statistics

Arithmetic Mean(0.08)
Coefficient Of Variation(312.12)
Mean Deviation0.12
Median(0.07)
Standard Deviation0.25
Sample Variance0.06
Range1.1658
R-Value(0.16)
Mean Square Error0.07
R-Squared0.03
Significance0.55
Slope(0.01)
Total Sum of Squares0.97

Foghorn Free Cash Flow Yield History

2025 -0.38
2024 -0.4
2023 -0.44
2022 0.73
2021 -0.063
2020 -0.0637
2019 -0.0709

About Foghorn Therapeutics Financial Statements

Foghorn Therapeutics investors use historical fundamental indicators, such as Foghorn Therapeutics' Free Cash Flow Yield, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Foghorn Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Yield(0.40)(0.38)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Foghorn Stock Analysis

When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.